BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 193 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2018. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299 | -99.9% | 5,960 | -49.6% | 0.01% | -68.9% |
| Q2 2022 | $597,000 | -13.2% | 11,819 | +9.8% | 0.04% | 0.0% |
| Q1 2022 | $688,000 | -31.0% | 10,769 | +15.6% | 0.04% | -64.0% |
| Q4 2021 | $997,000 | +232.3% | 9,312 | +219.1% | 0.12% | +212.5% |
| Q3 2021 | $300,000 | -64.4% | 2,918 | -73.0% | 0.04% | -86.0% |
| Q2 2020 | $843,000 | -44.1% | 10,813 | -58.0% | 0.29% | -55.0% |
| Q1 2020 | $1,507,000 | +237.1% | 25,763 | +350.2% | 0.64% | +561.5% |
| Q3 2018 | $447,000 | – | 5,722 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |